The addition of Caption AI to the handheld ultrasound device Vscan Air SL may facilitate optimal imaging for point-of-care cardiac evaluation.
In order to expand access to cardiac assessments via point-of-care ultrasound, GE HealthCare has added Caption AI capability to its Vscan Air SL handheld ultrasound device.
Through Caption AI’s use of artificial intelligence (AI)-enabled guidance to assist with ultrasound probe placement and imaging, GE HealthCare said the software can promote greater confidence in the use of Vscan Air SL to perform timely cardiac evaluation, even for those clinicians who lack ultrasound expertise.
In addition to a sector-phased array transducer, the Vscan Air SL also has an AutoEF feature, which provides automated calculation of left ventricular ejection fraction (LVEF), according to GE HealthCare.
The company suggested that the expanded capabilities of Vscan Air SL with Caption AI, which will be showcased at the American College of Cardiology (ACC) Annual Scientific Session and Expo later this week in Atlanta, could have an impact for earlier detection of heart disease in patients at resource-challenged facilities.
"With the increase of cardiovascular disease and shortage of sonographers around the globe, innovations like the Vscan Air SL with Caption AI are hugely transformative in cardiac care, supporting rapid and confident assessments at the point of care," said cardiologist Jordan B. Strom, M.D., MSc, an assistant professor of medicine at Harvard Medical School and director of echocardiographic research at the Beth Israel Deaconess Medical Center in Boston.
MRI-Based Deep Learning Algorithm Shows Comparable Detection of csPCa to Radiologists
May 8th 2024In a study involving over 1,000 visible prostate lesions on biparametric MRI, a deep learning algorithm detected 96 percent of clinically significant prostate cancer (csPCa) in comparison to a 98 percent detection rate for an expert genitourinary radiologist.
FDA Clears AI-Powered Qualitative Perfusion Mapping for Cone-Beam CT
May 6th 2024Reportedly validated in more than 10 clinical trials, the AngioFlow perfusion imaging software enables timely identification of brain regions with cerebral blood flow reduction and those with significant hypoperfusion.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
European Society of Breast Imaging Issues Updated Breast Cancer Screening Recommendations
April 24th 2024One of the recommendations from the European Society of Breast Imaging (EUSOBI) is annual breast MRI exams starting at 25 years of age for women deemed to be at high risk for breast cancer.